Page 9 - Indian Pharma Companies

Dr Reddy's applies for emergency use approval for Sputnik V vaccine

Aims to launch the vaccine in March if regulator approval comes through

Covid-19 drugs among top-selling brands for pharma players in India

Data shows that cumulative sales of remdesivir was Rs 510 crore in January 2021, while for favipiravir it was Rs 471 crore

PLI scheme may trigger investments worth Rs 50,000 crore into pharma sector

According to the people, 86 companies have applied to start production of bulk drugs listed under the PLI scheme so far, said sources

Sales of Ivermectin, drug to treat parasitic infections, jump fourfold

Mumbai-based pulmonologist Dr Agam Vora said in the first few months of the pandemic, the line of treatment was not established

Market reacts negatively to Biocon's weaker results, exit of biologics' MD

Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"

India to start Covid-19 vaccine exports on Wednesday, says report

The foreign ministry said shipments would start on Wednesday following requests from "neighbouring and key partner countries"

India and smug mediocrity

Indian democracy is equating excellence with elitism

Covid vaccination drive: India well prepared to store, distribute vaccines

India has about 29,000 cold chain points, 1.6 million shipper boxes, 76,000 cold chain equipment, 700 reefer vans and 55,000 cold chain handlers

Bharat Biotech concludes recruitment for Covaxin's phase 3 study

Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee

Bharat Biotech: A journey that started with a scientist's return to India

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India

A jab at risk: Serum's quest to lead the world in Covid-19 vaccine race

It took a chance by ramping up capacity on vaccines when they were yet to be approved and is set to emerge a global winner

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India

The story behind the rise of Serum Institute, world's vaccine factory

Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses

Zydus Cadila receives drug regulator's nod for NAFLD medicine in India

ZydusCadila said it has received approval from the Drug Controller General of India (DCGI) for Saroglitazar Mg, used for the treatment of non-alcoholic fatty liver disease (NAFLD), in the country

Health Minister inaugurates India's first pneumococcal conjugate vaccine

Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India

We are researching two candidates for Covid vaccines: Serum Institute CEO

In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity

Pharma revenue, margins likely to remain healthy in next fiscal: ICRA

Revenue growth for IPM (Indian Pharmaceutical Market) is expected to be 7-9 per cent in FY2021 despite muted growth in Q1 FY2021

Vial, syringe makers push the pedal as Covid-19 vaccine roll-out nears

Most firms plan to increase capacity to meet fresh orders

Shelf life of vaccines likely to be more than 3 months, unlike drugs

They have the stability data for these investigational products, said a source

India's first mRNA Covid-19 vaccine gets nod to start phase 1 trials

The Central Drugs Standard Control Organisation permitted Pune-based Gennova Biopharmaceuticals to conduct Phase 1/2 clinical trials for its mRNA Covid-19 vaccine candidate